GlassScriptPhysician profile
Jon N Swift
NPI 1780649079
$6,337.79
in general payments reported to CMS, 2019-2025
25 companies · $916 in 2025
The $916 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,534 · 2020: $586 · 2021: $799 · 2022: $1,214 · 2023: $633 · 2024: $656 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,204.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,443.95 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Abbott Laboratories | $1,237.64 | 2021-2025 | Eterna, Proclaim |
| Nevro Corp. | $712.79 | 2019-2024 | Senza |
| Nalu Medical, INC. | $683.22 | 2021-2025 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $660.82 | 2019-2020 | |
| Si-Bone, INC. | $311.91 | 2019-2024 | |
| Medtronic, INC. | $197.07 | 2022-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Synchromedii |
| Globus Medical, INC. | $147.93 | 2025 | Senza |
| Neuronetics, INC. | $138.75 | 2019 | |
| Bioventus LLC | $110.69 | 2019-2024 | Durolane |
| Ossur Americas, INC. | $109.80 | 2024 | Miami J |
| Pacira Therapeutics, INC. | $95.30 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $85.92 | 2022-2024 | Iovera, Zilretta |
| Saluda Medical Americas, INC. | $78.39 | 2025 | Evoke |
| Ferring Pharmaceuticals INC. | $57.00 | 2019-2023 | Euflexxa |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $51.97 | 2019-2025 | Monovisc |
| Vertos Medical, INC. | $46.18 | 2024 | Mild Device Kit |
| Ge Healthcare | $42.82 | 2019 | |
| Biotronik Nro, INC. | $24.71 | 2025 | Prospera |
| Amgen INC. | $23.33 | 2019 | |
| Collegium Pharmaceutical, INC. | $21.13 | 2020 | |
| Arbor Pharmaceuticals, INC. | $15.94 | 2019 | |
| Heron Therapeutics, INC. | $14.25 | 2022 | |
| Merz North America, INC. | $13.34 | 2020 | |
| Biodelivery Sciences International, INC. | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Swift listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.